Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances

Go back to Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances
(AMEX: VSQTF) Delayed: 0.32 +0.02 (6.67%)
Previous Close $0.30    52 Week High $ 
Open $0.32    52 Week Low $ 
Day High $0.32    P/E N/A 
Day Low $0.32    EPS $ 
Volume 3,490       

(NYSE: VST) Delayed: 156.14 +5.82 (3.87%)
Previous Close $150.32    52 Week High $ 
Open $153.35    52 Week Low $ 
Day High $158.74    P/E N/A 
Day Low $151.83    EPS $ 
Volume 5,070,628